Combination Effect of MicroRNA-۱۵a and MicroRNA-۱۶-۱ on Chemosensitivity of the Leukemia Cells

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 128

فایل این مقاله در 14 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_REMJ-11-4_006

تاریخ نمایه سازی: 30 تیر 1404

چکیده مقاله:

Background: Down-regulation of miRNA-۱۵a and miRNA-۱۶-۱ is associated with Bcl-۲ and Mcl-۱ expression and chemoresistance in tumor cells. In this study, the combined effect of miRNA-۱۵a and miRNA-۱۶-۱ on apoptosis and sensitivity of the chronic lymphocytic leukemia (CLL) cells to fludarabine and ABT-۱۹۹ was investigated. Materials and Methods: The experiment groups were as follows: ABT-۱۹۹, negative control (NC) miRNA, miRNA-۱۵a, miRNA-۱۶, miRNA-۱۵a+miRNA-۱۶, NC miRNA+ABT-۱۹۹, miRNA-۱۵a+miRNA-۱۶+ABT-۱۹۹, erlotinib blank control, miRNA blank control and combination blank control. The expression levels of Bcl-۲ and Mcl-۱ were measured using quantitative real-time PCR (qRT-PCR). The effect of treatments on cell growth and survival was measured by trypan blue staining and MTT (۳-[۴, ۵ dimethylthiazol-۲-yl]-۲, ۵ diphenyltetrazolium bromide) assay, respectively. Apoptosis was measured using caspase-۳ activity and ELISA cell death assays. Results: Transfection of miRNA-۱۵a or miRNA-۱۶-۱ significantly suppressed the expression of Bcl-۲ and Mcl-۱ in a time-dependent manner (P<۰.۰۵ versus negative control miRNA or blank control). Other experiments showed that up-regulation of miRNA-۱۵a or miRNA-۱۶-۱ decreased cell growth, induced apoptosis, and synergistically lowered the IC۵۰ value of fludarabine and ABT-۱۹۹ in CLL cells. Moreover, co-transfection of two miRNAs showed a more significant effect on cell survival, apoptosis, and drug sensitivity than single transfection. Conclusion: Our study shows that miRNA-۱۵a and miRNA-۱۶-۱ can effectively enhance the anticancer effects of fludarabine and ABT-۱۹۹ in CLL cells and may offer a new promising therapeutic strategy for CLL-resistant patients.

نویسندگان

Nooshin Ashofteh

Students Research Committee, Arak University of Medical Sciences, Arak, Iran

Razieh Amini

Department of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran

Alireza Amani

Department of Orthopedic, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran

Hadi karami

Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Danilov AV. Targeted therapy in chronic lymphocytic leukemia: past, present, ...
  • Ashofteh N, Amini R, Molaee N, Karami H, Baazm M. ...
  • Chen R, Plunkett W. Strategy to induce apoptosis and circumvent ...
  • Ma S, Rosen ST. Signal transduction inhibitors in chronic lymphocytic ...
  • Masood A, Shahshahan MA, Jazirehi AR. Novel approaches to modulate ...
  • Arnason JE, Brown JR. Targeted therapy for chronic lymphocytic leukemia: ...
  • Fegan C, Pepper C. Apoptosis deregulation in CLL. Advances in ...
  • Billard C. Design of novel BH۳ mimetics for the treatment ...
  • Thijssen R, Slinger E, Weller K, Geest CR, Beaumont T, ...
  • Bojarczuk K, Sasi BK, Gobessi S, Innocenti I, Pozzato G, ...
  • Wang Q, Wan J, Zhang W, Hao S. MCL-۱ or ...
  • Alamdari-Palangi V, Amini R, Karami H. MiRNA-۷ enhances erlotinib sensitivity ...
  • Yin Z, Xu M, Li P. miRNA-۲۲۱ acts as an ...
  • Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, ...
  • Hallek M. Chronic lymphocytic leukemia: ۲۰۲۰ update on diagnosis, risk ...
  • Lia M, Carette A, Tang H, Shen Q, Mo T, ...
  • Liu Q, Fu H, Sun F, Zhang H, Tie Y, ...
  • Amri J, Molaee N, Karami H. Up-Regulation of MiRNA-۱۲۵a-۵p Inhibits ...
  • Amri J, Molaee N, Karami H, Baazm M. Combination of ...
  • Shahverdi M, Amini R, Amri J, Karami H. Gene Therapy ...
  • Alamdari-Palangi V, Karami Z, Karami H, Baazm M. MiRNA-۷ Replacement ...
  • Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, ...
  • Tam CS, Seymour JF, Roberts AW. Progress in BCL۲ inhibition ...
  • Bannerji R, Kitada S, Flinn IW, Pearson M, Young D, ...
  • Pepper C, Thomas A, Hoy T, Bentley P. Chlorambucil resistance ...
  • Pepper C, Lin TT, Pratt G, Hewamana S, Brennan P, ...
  • Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ. ...
  • Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, ...
  • Phillips DC, Jin S, Gregory GP, Zhang Q, Xue J, ...
  • Zhou XX, Wang X. Role of microRNAs in chronic lymphocytic ...
  • Moussay E, Palissot V, Vallar L, Poirel HA, Wenner T, ...
  • Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu ...
  • Ferracin M, Zagatti B, Rizzotto L, Cavazzini F, Veronese A, ...
  • Lam LT, Lu X, Zhang H, Lesniewski R, Rosenberg S, ...
  • Chen J, Zhang X, Lentz C, Abi-Daoud M, Paré GC, ...
  • Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. ...
  • نمایش کامل مراجع